🇺🇸 FDA
Patent

US 10400253

Methods and compositions or RNA-directed target DNA modification and for RNA-directed modulation of transcription

granted A61KA61K38/465A61K48/00

Quick answer

US patent 10400253 (Methods and compositions or RNA-directed target DNA modification and for RNA-directed modulation of transcription) held by The Regents of the University of California expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K38/465, A61K48/00, A61P, A61P31/00